Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds: A clinical and positron emission tomography - Computed tomography analysis

International Orthopaedics

Volumn 37, Issue 11, 2013, Pages 2231-2237

  Petri, Maximilian ^a   Namazian, Ali ^a   Wilke, Florian ^a   Ettinger, Max ^a   Stübig, Timo ^a   Brand, Stephan ^a   Bengel, Frank ^a   Krettek, Christian ^a   Berding, Georg ^a   Jagodzinski, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Mesenchymal stem cells (MSC); Scaffold; Segmental bone defect; Stem cell concentrate

Indexed keywords

FLUORIDE;

ARTICLE; BLOOD FLOW; BONE DEFECT; BONE DENSITY; BONE MARROW BIOPSY; CELL COUNT; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; FRACTURE HEALING; HUMAN; LEUKOCYTE; LONG BONE; MESENCHYMAL STEM CELL TRANSPLANTATION; OSSIFICATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANIMALS; BONE DISEASES; BONE TRANSPLANTATION; CATTLE; FEMUR; FLUORIDES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOGENESIS; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 84887169162     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-013-2087-y     Document Type: Article

References (25)

1. Jager M, Herten M, Fochtmann U et al (2011) Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 29(2):173-180
2. Al-Zube L, Breitbart EA, O'Connor JP et al (2009) Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res 27(8):1074-1081
3. Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2(2-3):81-96
4. Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2(1):1-13
5. Ghodadra N, Singh K (2008) Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biogeosciences 2(3):345-354
6. Giannoudis PV, Tzioupis C (2005) Clinical applications of BMP-7: the UK perspective. Injury 36(Suppl 3):S47-S50
7. Dimitriou R, Dahabreh Z, Katsoulis E et al (2005) Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36(Suppl 4):S51-S59 (Pubitemid 41608591)
8. Graham S, Leonidou A, Lester M et al (2009) Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs 18(11):1633-1654
9. Hollinger JO, Hart CE, Hirsch SN et al (2008) Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90(Suppl 1):48-54 (Pubitemid 351329121)
10. Hollinger JO, Onikepe AO, MacKrell J et al (2008) Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26(1):83-90
11. Kasten P, Vogel J, Geiger F et al (2008) The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29(29):3983-3992
12. Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35(9):1271-1280
13. Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31(6):721-727 (Pubitemid 350160314)
14. Hendrich C, Franz E, Waertel G et al (2009) Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients. Orthop Rev (Pavia) 1(2):e32
15. Jager M, Jelinek EM, Wess KM et al (2009) Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 4(1):34-43
16. Gessmann J, Köller M, Godry H et al (2012) Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia) 4(1):e14
17. Schliephake H, Berding G, Knapp WH, Sewilam S (1999) Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography. Int J Oral Maxillofac Surg 28(5):349-355
18. Guda T, Walker JA, Singleton BM et al (2013) Guided bone regeneration in long-bone defects with a structural hydroxyapatite graft and collagen membrane. Tissue Eng Part A 19(17-18):1879-1888
19. Reichert JC, Cipitria A, Epari DR et al (2012) A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med 4(141):141ra93
20. Goshima K, Nakase J, Xu Q et al (2012) Repair of segmental bone defects in rabbit tibia promoted by a complex of beta-tricalcium phosphate and hepatocyte growth factor. J Orthop Sci 17(5):639-648
21. Sauerbier S, Rickert D, Gutwald R et al (2011) Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial-per-protocol analysis. Tissue Eng Part A 17(17-18):2187-2197
22. Rickert D, Sauerbier S, Nagursky H et al (2011) Maxillary sinus floor elevation with bovine bone mineral combined with either autogenous bone or autogenous stem cells: a prospective randomized clinical trial. Clin Oral Implants Res 22(3):251-258
23. Zhong W, Sumita Y, Ohba S et al (2012) In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One 7(7):e40833
24. Cao L, Liu G, Gan Y et al (2012) The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Biomaterials 33(20):5076-5084
25. Buttaro MA, Constantini J, Comba F, Piccaluga F (2012) The use of femoral struts and impacted cancellous bone allograft in patients with severe femoral bone loss who undergo revision total hip replacement: a three- to nine-year follow-up. J Bone Joint Surg Br 94(2):167-172